A. Hoeben

Vaassen, F., Hofstede, D., Zegers, C. M. L., Dijkstra, J. B., Hoeben, A., Anten, M. H. M. E., Houben, R. M. A., Hoebers, F., Compter, I., van Elmpt, W., & Eekers, D. B. P. (2025). The effect of radiation dose to the brain on early self-reported cognitive function in brain and head-and-neck cancer patients. Clinical and Translational Radiation Oncology, 52, Article 100929. https://doi.org/10.1016/j.ctro.2025.100929

Hamulyák, E. N., Wang, T.-F., Kreuziger, L. B., Iyengar, V., Carney, B. J., Hoeben, A., Özdemir, B. C., Serrano, R. D. C., Sanfilippo, K. M., Rozenblatt, S., Beenen, L. F. M., Yust-Katz, S., Halperin, E., Arad, A., Lubetsky, A., Carrier, M., Massat, B., Büller, H. R., Spectre, G., ... ten Cate, H. (2025). Multinational cohort study of intracranial hemorrhage in patients with brain metastases receiving anticoagulation. Haematologica-the Hematology Journal. Advance online publication. https://doi.org/10.3324/haematol.2024.286973

Verhees, F., Demers, I., Legemaate, D., Jacobs, R., Hoeben, A., Kremer, B., & Speel, E.-J. (2025). Exploring the antiproliferative effect of PI3K/Akt/mTOR pathway and CDK4/6 inhibitors in human papillomavirus-positive and -negative head and neck squamous cell carcinoma cell lines. International Journal of Oncology, 66(2), Article 13. https://doi.org/10.3892/ijo.2025.5719

de Leeuw, A. L. M. P., Giralt, J., Tao, Y., Benavente, S., Nguyen, T.-V. F., Hoebers, F. J. P., Hoeben, A., Terhaard, C. H. J., Lee, L. W., Friesland, S., Steenbakkers, R. J. H. M., Tans, L., van Kranen, S. R., van de Kamer, J. B., Bartelink, H., Rasch, C. R. N., Sonke, J.-J., & Hamming-Vrieze, O. (2025). Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer. Radiotherapy and Oncology, 202, Article 110612. https://doi.org/10.1016/j.radonc.2024.110612

Florie, M. G. M. H., Wieland, M. W. M., Pilz, W., Partoens, R., Winkens, B., Hoeben, A., Rommel, N., & Baijens, L. W. J. (2025). Prevalence and Risk Factors of Oropharyngeal Dysphagia in Newly Diagnosed Head-and-Neck Cancer Patients. Cancers, 17(1), Article 9. https://doi.org/10.3390/cancers17010009

Verkerk, K., van der Wel, T. J. W. T., Zeverijn, L. J., Geurts, B. S., Spiekman, I. A. C., de Wit, G. F., Roepman, P., Jansen, A. M. L., van der Noort, V., Smit, E. F., Hoeben, A., Hendriks, L. E. L., Van den Heuvel, M. M., Piet, B., Herder, G. J. M., Hashemi, S. M. S., Gelderblom, H., Verheul, H. M. W., Voest, E. E., & de Langen, A. J. (2024). Safety, Efficacy and Biomarker Analysis of Crizotinib in MET Mutated Non-Small Cell Lung Cancer - Results from the Drug Rediscovery Protocol. Clinical Cancer Research, 30(23), 5323-5332. https://doi.org/10.1158/1078-0432.CCR-24-1925

Geurts, B. S., Zeverijn, L. J., Leek, L. V. M., van Berge Henegouwen, J. M., Hoes, L. R., van der Wijngaart, H., van der Noort, V., van de Haar, J., van Ommen-Nijhof, A., Kok, M., Roepman, P., Jansen, A. M. L., de Leng, W. W. J., de Jonge, M. J. A., Hoeben, A., van Herpen, C. M. L., Westgeest, H. M., Wessels, L. F. A., Verheul, H. M. W., ... Voest, E. E. (2024). Efficacy of pembrolizumab and biomarker analysis in patients with WGS-based intermediate to high tumor mutational load: results from the Drug Rediscovery Protocol. Clinical Cancer Research, 30(17), 3735-3746. https://doi.org/10.1158/1078-0432.CCR-24-0011

Hoosemans, L., Vooijs, M., & Hoeben, A. (2024). Opportunities and Challenges of Small Molecule Inhibitors in Glioblastoma Treatment: Lessons Learned from Clinical Trials. Cancers, 16(17), Article 3021. https://doi.org/10.3390/cancers16173021

de Leeuw, A. L. M. P., Giralt, J., Tao, Y., Benavente, S., France Nguyen, T.-V., Hoebers, F. J. P., Hoeben, A., Terhaard, C. H. J., Wai Lee, L., Friesland, S., Steenbakkers, R. J. H. M., Tans, L., Heukelom, J., Kayembe, M. T., van Kranen, S. R., Bartelink, H., Rasch, C. R. N., Sonke, J.-J., & Hamming-Vrieze, O. (2024). A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE). Radiotherapy and Oncology, 196, Article 110281. https://doi.org/10.1016/j.radonc.2024.110281

Jacquerie, A., Hoeben, A., Eekers, D. B. P., Postma, A. A., Vanmechelen, M., de Smet, F., Ackermans, L., Anten, M., Severens, K., zur Hausen, A., Broen, M. P. G., & Beckervordersandforth, J. (2024). Prognostic relevance of high expression of kynurenine pathway markers in glioblastoma. Scientific Reports, 14(1), Article 14975. https://doi.org/10.1038/s41598-024-65907-3